The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
HSD3B1 (1245A>C) polymorphism and clinical outcomes in metastatic castration-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate (AA) and enzalutamide (ENZA): Results from two prospective studies.
 
Isabel Aragon
No Relationships to Disclose
 
Daniel Joseph Khalaf
Honoraria - Bayer
Consulting or Advisory Role - Bayer
 
Rebeca Lozano
Consulting or Advisory Role - Sanofi/Aventis
Speakers' Bureau - Janssen-Cilag; Roche
Research Funding - Bayer (Inst); Janssen (Inst)
Travel, Accommodations, Expenses - Janssen-Cilag; Roche
 
Matti Annala
No Relationships to Disclose
 
Sinja Taavitsainen
No Relationships to Disclose
 
David Lorente
Consulting or Advisory Role - Bayer; Janssen; Sanofi
Speakers' Bureau - Astellas Pharma; Bayer Health; Janssen; Sanofi
Travel, Accommodations, Expenses - Astellas Pharma; Celgene; Janssen; Sanofi
 
Daygen L. Finch
Consulting or Advisory Role - Astellas Amgen BioPharama; Bayer; Janssen
 
Nuria Romero-Laorden
Consulting or Advisory Role - AstraZeneca; Bayer; Ipsen; Ipsen; Tesaro
Speakers' Bureau - Astellas Pharma; Janssen-Cilag; Pfizer; Roche; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Janssen-Cilag (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Janssen-Cilag; Pfizer; Roche
 
Joanna Vergidis
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Merck; Pfizer
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Janssen
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Merck
 
Ylenia Cendon
No Relationships to Disclose
 
Conrad D. Oja
No Relationships to Disclose
 
Maria I Pacheco
No Relationships to Disclose
 
Muhammad Zulfiqar
No Relationships to Disclose
 
Martin Gleave
Stock and Other Ownership Interests - OncoGenex
Honoraria - Astellas Pharma; Bayer; Genova Diagnostics; Janssen; Pfizer; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Genova Diagnostics; Janssen; Pfizer; Sanofi
Research Funding - Astellas Pharma; Bayer; Janssen
Patents, Royalties, Other Intellectual Property - OncoGenex - OGX-011, OGX-427; ST-CP; ST-POP
 
Alexander William Wyatt
Honoraria - Bayer; Janssen
Consulting or Advisory Role - AstraZeneca
Research Funding - Janssen
 
David Olmos
Honoraria - Astellas Pharma (Inst); Bayer; Janssen
Consulting or Advisory Role - AstraZeneca (Inst); Bayer; Bayer (Inst); Clovis Oncology; Janssen; Janssen (Inst)
Research Funding - Astellas Medivation (Inst); AstraZeneca (Inst); Bayer (Inst); Genentech/Roche (Inst); Janssen (Inst); Pfizer (Inst); Tokai Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Ipsen; Janssen
 
Elena Castro
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Janssen-Cilag; Pfizer
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Janssen; Merck
Research Funding - AstraZeneca (Inst); Bayer (Inst); Janssen (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bayer; Janssen; Roche
 
Kim N. Chi
Honoraria - Astellas Pharma; Bayer; Janssen; Sanofi
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; ESSA; Janssen; Roche; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen (Inst); Lilly/ImClone (Inst); Merck (Inst); Roche (Inst); Sanofi (Inst); Tokai Pharmaceuticals (Inst)